Back to search

Article

Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trial

2022-11-15

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Advanced cell therapeutics are emerging as potentially effective treatments for chronic neurological diseases, including secondary progressive multiple sclerosis (SPMS). Here we report the results of a phase I trial in which good manufacturing practice-grade foetal allogeneic human neural stem cells (hNSCs) were implanted via intracerebroventricular (ICV) injection in 15 indiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e8702f3-9c6c-5159-8e54-555c819aecd8
DOI
10.1101/2022.11.14.22282124
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trialDOI 10.1101/2022.11.14.22282124
Select a neighboring publication to make it the new centre.